+454.2%
MRNA vs VG
+12.9%
+441.3%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | VG | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | +3.8% | -7.2% | -3.0% |
| 7D | -10.1% | +3.8% | -13.9% | -9.7% |
| 30D | +126.7% | +7.2% | +119.5% | +129.4% |
| 3M | +184.1% | +22.8% | +161.3% | +187.0% |
| 6M | +143.3% | +33.2% | +110.1% | +137.5% |
| YTD | +359.9% | +124.8% | +235.0% | +295.0% |
| 1Y | +454.2% | +15.8% | +438.4% | +417.5% |
| All | +454.2% | +12.9% | +441.3% | +417.5% |
Cumulative growth
Daily Returns
Daily percentage return beside VG.
Daily Out/Under-Performance
Portfolio return minus VG return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VG return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded VG wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling